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SUMMARY
Planning of the control of Plasmodium falciparum malaria leads to a need for models of malaria epidemiology that provide
realistic quantitative prediction of likely epidemiological outcomes of a wide range of control strategies. Predictions of
the eﬀects of control often ignore medium- and long-term dynamics. The complexities of the Plasmodium life-cycle, and
of within-host dynamics, limit the applicability of conventional deterministic malaria models. We use individual-based
stochastic simulations of malaria epidemiology to predict the impacts of interventions on infection, morbidity, mortality,
health services use and costs. Individual infections are simulated by stochastic series of parasite densities, and naturally
acquired immunity acts by reducing densities. Morbidity and mortality risks, and infectiousness to vectors, depend on
parasite densities. The simulated infections are nested within simulations of individuals in human populations, and linked
to models of interventions and health systems. We use numerous ﬁeld datasets to optimise parameter estimates. By using a
volunteer computing system we obtain the enormous computational power required for model ﬁtting, sensitivity analysis,
and exploration of many diﬀerent intervention strategies. The project thus provides a general platform for comparing,
ﬁtting, and evaluating diﬀerent model structures, and for quantitative prediction of eﬀects of diﬀerent interventions and
integrated control programmes.
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INTRODUCTION
‘‘Hubris seems to be the chief vice of the model builder without,
and even with, ﬁeld experience. It induces justiﬁed scepticism
and is counter-productive. It serves only to convince the
determinedly non-numerate public health worker that models
are a seductive alternative to understanding ’’ (Bradley,
1982).
‘‘… and perhaps none will fully understand the behaviour of
the whole system as it operates within the economic, social and
political constraints of a given society. This may explain some
of the diﬃculties of predicting with suﬃcient accuracy the
likely consequences of any chosen strategy of intervention. And
if one cannot predict the consequences of a given strategy, one
had no rational basis for choosing between the available al-
ternatives. ’’ (Bailey, 1982).
Mathematical modelling of malaria transmission
dynamics goes back to Ross, who described the
population dynamics of malaria and identiﬁed ento-
mological thresholds for elimination (Ross, 1911).
In the 1950s, as the emergence of indoor residual
spraying made the elimination of malaria over wide
areas conceivable, Ross’ work was further developed
by Macdonald and others, who provided the math-
ematical explanation of the eﬀect of reduction of
mosquito longevity on malaria transmission, es-
pecially through the concept of the basic repro-
duction number (Macdonald, 1957). Later models
incorporated superinfection and immunity (Dietz,
Molineaux and Thomas, 1974), linked to a ﬁeld
investigation of the feasibility of malaria elimination
in the West African savannah (Molineaux and
Gramiccia, 1980). The focus of malaria modelling up
until then (reviewed in detail by Bailey (1982)) was
on transmission dynamics, and in particular strat-
egies for eliminating the parasite.
Models of malaria dynamics have continued to be
developed (e.g. Aron, 1988; Struchiner, Halloran
and Spielman, 1989; McKenzie and Bossert, 2005)
but a very diﬀerent kind of modelling became
prominent in the last few decades of the 20th century
when control programmes, especially in Africa,
focused on reducing morbidity and mortality rather
than suppressing transmission. Elimination had
proven unrealistic in tropical Africa and had been
given up in most tropical countries in Asia and the
Americas following severe setbacks. New interven-
tions considered suitable for long-term control were
validated through large-scale ﬁeld trials. This motiv-
ated the development of predictive models that use
empirical estimates of the eﬀectiveness of interven-
tions, studies on disease burden, and unit costs
to quantify morbidity and mortality and likely
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cost-eﬀectiveness of interventions. Examples include
the work ofGoodman, Coleman andMills (2000) and
Rowe et al. (2007). In such models, epidemiological
impact is generally inferred from ﬁeld trial results,
which assess only short-term eﬀects using well-
controlled delivery systems, and there is no explicit
consideration of the dynamics of transmission and
immunity, in particular the loss of population im-
munity that results from decreased transmission.
With a yearly toll of the order of one million lives,
malaria remains the main cause of death in young
children in Africa (Roll Back Malaria, 2005). The
disease has therefore become one of the top priorities
on the international health agenda. There are a
number of eﬃcacious interventions such as insecti-
cide treated nets (ITNs), indoor residual spraying
(IRS) and artemisinin-based combination therapy
(ACT) but it is not obvious what will be their impact,
taking into consideration eﬀects on transmission and
health system constraints, and so it is not obvious
when and how best to deploy and combine them.The
resource allocation issues are considerable, with
current estimates of US$ 3.8 to 4.5 billion per year
for the total costs of controlling malaria worldwide
in accordance with internationally agreed targets
(Kiszewski et al. 2007) and the actual annual inter-
national transfers for malaria control increasing year
by year, reaching USD 600 million in 2006 (Roll
Back Malaria, 2005). Ongoing ﬁeld research as well
as programme monitoring and evaluation is essential
to decide on the best strategies in diﬀerent contexts,
but it is not realistic to ﬁeld-test a large number of
combinations of diﬀerent interventions in diﬀerent
epidemiological and operational settings.
The planning and prioritization of integrated
control strategies thus need models that can quantify
both short- and long-term eﬀects on transmission,
morbidity, mortality, immunity and resistance to
medicines and insecticides, at the same time as in-
corporating ﬁeld-based data about control, including
health system information. Unfortunately there have
been very few examples of disease modelling span-
ning transmission dynamics as well as economic
factors, and these have been constrained by the ap-
plication of limited sets of ﬁeld data to linear models
and limited combinations of interventions (Flessa,
2002). This paper is an overview of the project we
are undertaking to develop such comprehensive
simulation models of malaria epidemiology and
control and to ﬁt them to ﬁeld data.
This project started when we undertook to develop
a model to simulate the potential eﬀects of the in-
troduction of pre-erythrocytic malaria vaccines. We
chose to address this problem using an individual-
based stochastic model, or micro-simulation ap-
proach. Micro-simulation is an increasingly popular
modelling technique (see for instance Stolk et al.
in this special issue) because it oﬀers almost total
ﬂexibility in the description both of inputs and
outputs, making it relatively easy to extend the
framework indeﬁnitely to mimic very complex sys-
tems, so that both short- and longer- term dynamics
can be considered at the same time. Moreover,
stochastic approaches lend themselves to modelling
rare events (such as deaths), and stochastic models
can be readily extended to model heterogeneities
as functions of distributions. Micro-simulations of
infectious disease control can reproduce arbitrary
aspects of interventions such as delivery to selected
groups of individuals, and also look at the impli-
cations of monitoring selected population sub-
groups, such as speciﬁc age groups or only those
with clinical symptoms. Despite this potential,
micro-simulations of human parasitic diseases have
so far had little impact on public health policy, with
the notable exception of the ONCHOSIM model
(Plaisier et al. 1990; Habbema et al. 1992), which
has proved an invaluable decision support tool
in the Onchocerciasis Control Programme in West
Africa.
The results of our initial simulations of pre-
erythrocytic malaria vaccines are already published
(for an overview see Smith et al. (2006a)). The ap-
proach lends itself to prediction of the potential
impact of any malaria intervention strategy under
consideration and we are now adapting it for fore-
casting the epidemiological and economic impact and
cost-eﬀectiveness of the whole range of malaria
control interventions, singly or combined, applied
across a broad range of epidemiological and health
system scenarios in malaria endemic areas. In the
next section of the paper we outline the major chal-
lenges that we face in meeting this ambitious goal.
We then describe how we have addressed these
challenges to develop amodel that can be of real value
for malaria control decision-makers and planners.
CHALLENGES
A general predictive model for malaria epidemiology
and control needs a parsimonious structure that
mimics malaria biology well enough to capture the
mechanisms of action of all the diﬀerent interven-
tions, and at the same time needs parameter values
that reproduce the observed quantitative relation-
ships between epidemiological measures. The sim-
ultaneous achievement of both these objectives is a
major challenge.
The biology and epidemiology of malaria com-
prises many diﬀerent dynamic processes with (posi-
tive and negative) feedback loops. Furthermore,
drug treatments, vector control, personal protection
and vaccines may all have eﬀects on outcomes that
are more complex than the eﬀects on primary infec-
tions in the non-immune host. Even if the eﬀect of a
vaccine is simply to reduce the force of infection,
the short-term consequences in terms of morbidity
and mortality are not simply proportional to the
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reduction in infection rate. There are also longer
term dynamic eﬀects due to changes in the immune
status of the population, beneﬁts due to herd im-
munity (in the case of vaccines), community eﬀects of
vector control, and long-term evolutionary conse-
quences (see, for instance, Koella and Zaghloul
(2008)). Predictions of long-term eﬀectiveness of
interventions in programmes also need to consider
the health system realities that result in sub-optimal
access, targeting accuracy, provider compliance, and
consumer adherence. Longer term eﬀects also in-
clude the ramiﬁcations with regard to health service
demands.
The core of a model that can capture all of these is
the speciﬁcation of the properties of an infection.
An individual malaria infection can last for many
months, during which densities of both asexual
parasites and gametocytes vary irregularly as conse-
quences mainly of the developmental cycle of the
parasite, of host immunity, and of antigenic variation
(in P. falciparum). Disease and death are associated
with high parasite densities, and the most obvious
impact of acquired immunity is in reducing parasite
densities. The irregularities in parasite densities lend
themselves to treatment as statistical ﬂuctuations.
Since the course of each infection is diﬀerent, and
the average behaviour is of less importance than the
extent of variation, convincing models for individual
infections (e.g. those of Molineaux et al. (2001) and
Gatton and Cheng (2004)) have adopted stochastic
simulation approaches, rather than treating the de-
velopment of an individual malaria infection as a
deterministic process.
A population model for predicting the impact of
interventions that modify parasite densities, such as
asexual blood stage vaccination, or treatment with
incompletely eﬀective drugs, must explicitly capture
relationships with parasite densities, and thus
needs to nest within it such a stochastic model for
individual infections. This constrains the whole
modelling process into the individual-based stoch-
astic framework. In addition to its advantages, the
stochastic approach also leads to challenges: stoch-
astic models are computationally demanding, and
are more diﬃcult to ﬁt to data than deterministic
equivalents. The ﬁtting of a complex stochastic
model to a wide range of diﬀerent epidemiological
outcomes pushes limits both in terms of algorithms
of multi-objective optimization and computational
resources. In particular, because death is a relatively
infrequent event, many tens of thousands of life-
histories must be simulated in order to generate
stable estimates of mortality rates that can be com-
pared with ﬁeld data.
Fitting of models to data aims to minimize the
uncertainty in our predictions, but a further challenge
is to identify and quantify the many uncertainties
that will remain. For instance, it is very diﬃcult to
quantify natural variation in exposure to mosquito
bites, because it is inﬂuenced profoundly by a
number of factors including, for example, micro-
environment, climate and human behaviour. Stat-
istical imprecision can be reduced by acquiring
more data, but doubts will remain in any attempt to
predict the future. We do not know what new inter-
ventions may be discovered, and the future costs of
malaria control commodities may develop almost
unpredictably in reaction to demand, raw material
prices, industrial innovation and other factors.
Other uncertainties, especially those that relate to
the human immune response to the parasite, arise
because we have not been able to measure the
relevantquantities, or donot knowwhat they are.The
lack of a proxy measure for protective immunity
is particularly a problem for vaccine development
but it also represents a challenge for the speciﬁcation
of models of disease dynamics. Finally, there are es-
pecially large uncertainties with regard to both
the performance of health systems and the health-
seeking behaviours of populations. This is partly
because of the limited extent of comprehensive health
systems research inmalaria endemic areas.Validation
of parameters for models of interventions and health
systems is constrained to relatively few sites with
thorough costing and eﬀectiveness studies of inter-
ventions in real life health systems.
EPIDEMIOLOGICAL MODELS
The ﬁrst phase of the project (from 2003–2005) fo-
cused on developing a single model for malaria epi-
demiology that reproduces the relevant aspects of
malaria biology. We used this to predict the likely
impact of pre-erythrocytic vaccines, including pro-
jections of the consequences of introducing such
vaccines into the Expanded Program on Im-
munization, for both malaria epidemiology (Maire
et al. 2006c) and vaccine cost-eﬀectiveness (Tediosi
et al. 2006a). This required us to develop simulations
of the malaria transmission cycle, of the course of
individual infections, of the risk of morbidity and
mortality as a function of transmission intensity, and
of the impact of the health systems on malaria in
endemic settings. The details of the models used,
including their justiﬁcation in terms of biology and
epidemiology have been published as a supplement
to the American Journal of Tropical Medicine and
Hygiene, of which the ﬁrst paper provides an over-
view, together with the mathematical description
(Smith et al. 2006c).
The simulated time-courses of parasite densities
are based on a description of parasite densities in
neurosyphilis patients who received therapeutic
P. falciparum infections. By placing parasite densities
as the centre of a causal web linking infection with its
downstream eﬀects (Fig. 1), we are able to reproduce
key features of malaria biology that are diﬃcult to
capture with other approaches.
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Notably, in our models as in the real world, the
main eﬀect of naturally acquired immunity to ma-
laria is to reduce infection density, rather than per-
sistence of the infection (Sama, Killeen and Smith,
2004; Sama et al. 2006). We model the probability
that a mosquito is infected when feeding as a stoch-
astic function of time-lagged asexual parasite den-
sities in the human host. This is a considerable
simpliﬁcation but does capture the important density
dependence demonstrated in experimental models
(Sinden et al. 2007). High parasite densities are also a
trigger of clinical malaria and are quantitatively re-
lated to severity of disease, and so in our simulations
these events occur when parasite densities exceed
given thresholds.
In the ﬁrst phase we concentrated on simulating
malaria epidemiology in sites where there are ﬁeld-
based measurements of the seasonal pattern in the
entomological inoculation rate (EIR). We introduce
infections into the simulated human population via a
stochastic process dependent on the average EIR,
allowing for annual periodicity (Smith et al. 2006b).
Because the presence of P. falciparum in the blood
does not prevent a new infection (superinfection),
the population model needs to simulate not just
single infections but also recurrent and concurrent
multiple infections. The subsequent parasite den-
sities are then sampled using 5-day time steps, where
the sampling distributions for the parasite densities
are derived from the time-trends in malaria therapy
data and from immunity parameters determined
from each simulated individual’s history of infection
(Maire et al. 2006b).
In the ﬁrst phase of the project the requirement
for ﬁeld measurements of the EIR restricted
us to simulating only areas of intense endemic
transmission. We generated the simulated infections
via Poisson processes (Smith et al. 2006b), in-
corporating both seasonality and the age dependence
that arises because larger people generally receive
more bites by mosquitoes by virtue of their larger
body surface (Port, Boreham and Bryan, 1980), but
neglecting the clustering in infection that certainly
occurs in malaria. Some people are more attractive to
mosquitoes than others (Knols, de Jong and Takken,
1995), and some live in micro-environments where
they are more exposed.
In high transmission scenarios it is reasonable to
treat transmission as homogeneous, and generate
mortality rates by simulating very large closed popu-
lations. This is equivalent to averagingmany smaller,
village size, simulations because the population
average level of transmission is not much aﬀected
by stochastic variation. In low transmission scenarios
it is important to consider both individual diﬀer-
ences in risk of infection and to simulate receptivity
(the risk of epidemics from imported infections)
in realistically-sized human populations. Stochastic
models are the natural way to achieve this, and we are
currently exploring diﬀerent distributional assump-
tions for transmission heterogeneity (Smith, 2008).
We expect to conﬁrm the eﬀects of heterogeneity on
the basic reproduction number, R0 (Smith et al.
2007), but it is unclear how important are the sec-
ondary consequences of individual diﬀerences in
risk, such as the stronger development of natural
immunity for high-risk persons.
MODELS OF INTERVENTION STRATEGIES
We plan to deﬁne and simulate a minimal essential
set of interventions, intervention combinations and
scale-up strategies for malaria control. Table 1 out-
lines an example of some among the many possible
strategies, each of which will be speciﬁed in detail,
and for each of which a model for action of the in-
terventions must be incorporated into the simu-
lations. Integrated strategies may simultaneously
include many diﬀerent interventions, the appropri-
ateness of which will depend on the epidemiological
setting and health system.
For case management of malaria we include the
eﬀects on morbidity, mortality and transmission.
Models of health system eﬀectiveness in intervention
delivery are an important part of the simulation of
any preventive and curative intervention, since the
eﬀectiveness can be aﬀected by constraints both on
the provider and the consumer side. Improvements
in the health system, such as rolling-out of rapid
diagnostic tests represent an important set of inter-
ventions that we aim to simulate. We also consider
the reduced burden on the health system resulting
from preventive interventions and case management.
Quantitative modelling of the feedbacks in health
systems is in its infancy, and so far we have completed
Fig. 1. Key causal factors and outcomes in the models of
malaria epidemiology and interventions. Abbreviations:
BSV: blood stage vaccine; MSTBV: mosquito stage
transmission blocking vaccine; PEV: pre-erythrocytic
vaccine; ITNs: insecticide treated nets; IRS: indoor
residual spraying.
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only a basic model based on data from Tanzania
(Tediosi et al. 2006b). We are currently revising this
to incorporate improved simulations of diagnosis,
drug action, referral, the contribution of the informal
sector, and of the implications of intermittent pre-
ventive treatment as well as transmission reducing
interventions.
Measurements of immune responses to malaria
have generally not demonstrated strong correlations
with protection (pre-clinical studies of mosquito
stage transmission blocking vaccines are exceptions
(Saul, 2008)). For this reason we have formulated
models of vaccine action in terms of the eﬀects on
clinical and parasitological outcomes, rather than
modelling immune eﬀectors. Our analyses of the
results of ﬁeld trials of a pre-erythrocytic vaccine
were compatible with a very simple such model,
namely, that such vaccines block a percentage of
sporozoite inoculations from reaching the blood.
This percentage may vary between human hosts, but
it seems no-one is completely protected from infec-
tion by such a vaccine (Maire et al. 2006a).
We can model mosquito-stage transmission
blocking vaccines similarly by assuming a deﬁned
proportionate reduction in the probability that a
mosquito becomes infected from any one feed. We
have also modelled blood stage vaccines by assuming
the immediate eﬀect to be reduction in parasite den-
sities. This assumptionmay be an over-simpliﬁcation
as vaccine-induced reduction in asexual blood stage
challenge very likely has complex eﬀects on parasite
dynamics. We are developing improved within-host
models based on stochastic simulations to include
interaction between asexual parasites and host im-
mune responses. We anticipate that these should
provide us with models for asexual blood stage vac-
cination and for the action of antimalarial drugs that
capture these dynamics.
Table 1. Summary of datasets used for parameterising the epidemiological models
Objective Included& Sources of data
Number of
scenarios$
Number of
data points*
Reference for
the analysis
Parasite densities in primary
infections by age of infection
No Collins and Jeﬀery
(1999)
n.a. 47 patients Maire et al.
(2006b)
Infectivity of humans to mosquitoes
by history of parasite density
No Collins and Jeﬀery
(2003)
n.a. 730 feeding
experiments
Ross et al.
(2006a)
Incidence of new infection in
previously treated children#
No Beier et al. (1994) 21 62 Smith et al.
(2006b)
Age pattern of incidence of new
infection in treated individuals#
Yes Molineaux and
Gramiccia (1980)
1 12 Smith et al.
(2006b)
Age- and seasonal patterns of
prevalence of infection#
Yes Molineaux and
Gramiccia (1980)
6 563 Maire et al.
(2006b)
Age- and seasonal patterns of
parasite density#
Yes Molineaux and
Gramiccia (1980)
6 563 Maire et al.
(2006b)
Age pattern of number of
concurrent infections#
Yes Maire et al. (2006b) ;
Owusu-Agyei et al.
(2002)
1 12 Maire et al.
(2006b)
Age pattern of incidence of clinical
malaria#
Yes Trape and Rogier
(1996); Kitua et al.
(1996)
3 31 Smith et al.
(2006c)
Age pattern of threshold parasite
density for clinical attacks#
Yes Rogier et al. (1996) 1 13 Smith et al.
(2006c)
Hospitalisation rate in relation to
prevalence in children
Yes See Ross et al. (2006b) 26 10£ Ross et al.
(2006b)
Age pattern of hospitalisation# Yes Marsh and Snow
(1999)
4 12 Ross et al.
(2006b)
Malaria speciﬁc mortality
in children#
Yes Snow et al. (1997) 9 9 Ross et al.
(2006b)
Infant mortality rate# Yes See Ross et al. (2006b). 11 11 Ross et al.
(2006b)
& This column indicates whether this objective is included in the simultaneous multi-objective ﬁtting of the model, or
whether the data are used to separately parameterise model components.
$ Some scenarios are used to predict several outcomes, so the total of this column does not equal the total of 61 scenarios
involved in ﬁtting the models.
* The number of data points is the sum over all scenarios and simulated survey periods of the number of age groups into
which the data were disaggregated for comparison with the model predictions.
# In relation to the seasonal pattern in the EIR.
£ Model predictions for this objective are compared with interpolations between the ﬁeld data points.
n.a. (not applicable) indicates that this objective is not included in the multi-objective optimisation.
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We base our models for the eﬀects of personal pro-
tection and vector control on discrete-time models of
the mosquito feeding cycle (Saul, Graves and Kay,
1990;Killeen and Smith, 2007).We have generalized
these models to incorporate the heterogeneity of
human and non-human animal hosts, and explicitly
model the diﬀerent stages of the mosquito feeding
cycle that can be targeted by diﬀerent interventions,
allowing the duration of the feeding cycle to vary
(Chitnis, Steketee and Smith, 2007). The model is
being parameterized to simulate the eﬀects of Indoor
Residual Spraying (IRS) and for simulating eﬀects
of Insecticide Treated Nets (ITNs) at various per-
formance levels of the health system. Combinations
of both interventions can also be simulated. For the
latter, we are considering the dynamics of mosquito
net coverage, to include the eﬀects of deterioration of
nets and loss of insecticidal eﬀects. These models
will be validated by simulating ﬁeld trials of ITNs.
Once these models are in the overall stochastic
simulation platform, we will be able not only to
simulate plausible vector control strategies, but also
integrated control involving multiple interventions.
SOFTWARE AND FITTING TO DATA
Our stochastic simulation models are highly
computation-intensive, and are implemented in the
general purpose programming languages Fortran 95
andC++ for performance and ﬂexibility. The speci-
ﬁcations of the scenario to be simulated are provided
in an input ﬁle written in Extensible Markup
Language (XML), and output is returned in the form
of text ﬁles containing predictions of age- and time-
speciﬁc epidemiological quantities (infection preva-
lence and density, multiplicity of infection, incidence
and severity of morbidity, mortality, and levels of
intervention coverage), allowing for eﬀects of mis-
diagnosis where necessary.
In our initial overview publication we listed a total
of 38 parameters in the overall model of malaria
epidemiology. Considering that this comprises
simulations of the whole transmission cycle, relevant
aspects of immunity, and of a wide range of mor-
bidity and mortality outcomes, this is not excessive,
but optimisation within a space of this dimension is
challenging.
Some of the current components of this model are
estimated independently of the others. Six of the
parameters are part of a statistical model for how
anaemia depends on infection status (Carneiro et al.
2006). This anaemia component does not feed back
into the rest of the model. Nor do values of ﬁve
parameters that quantify infectivity of human hosts
to mosquitoes aﬀect the estimates of the rest of the
parameters and these were estimated in stand-alone
exercises (Ross, Killeen and Smith, 2006a ; Killeen,
Ross and Smith, 2006). Two other components of
the models are estimated directly from ﬁeld data,
namely, the time-course of parasite densities in
individual infections in a previously untreated
host, which is based on a statistical description of
malaria therapy proﬁles (Maire et al. 2006b) ; and
the relationship between the force of infection
(parasitological inoculation rate) and the EIR, which
is estimated from the data of a ﬁeld study that
speciﬁcally addressed this question (Beier et al.
1994). Malaria attributable neonatal mortality rates
are taken from systematic reviews (Ross and Smith,
2006).
The other components of the model, correspond-
ing to 25 diﬀerent unknown quantities (parameters),
are ﬁtted by treating the stochastic simulation as an
implicit statistical model (a list of these parameters is
given by Smith et al. (2006a). A total of 61 standard
scenarios have been constructed, corresponding to
sites where both the pattern of transmission and
one or more epidemiological variables have been
measured (Table 2). These epidemiological variables
deﬁne a set of 10 diﬀerent objective functions (like-
lihoods or sums of squares) corresponding to diﬀer-
ent epidemiological outcome measures that must be
optimised. In the ﬁrst phase of the project we were
able to ﬁt our model to all of these objectives using a
simulated annealing algorithm. We used a desktop-
grid approach to distribute the simulations across our
local computer network, using up to 40 processors
at any one time. However this was only possible by
ﬁtting the diﬀerent objectives and corresponding
model components sequentially, each conditional on
the upstream objectives. Even then, many of the
optimisation runs required several weeks of com-
puting. The computational demands were particu-
larly high for the large number of scenarios used
for predicting rates of severe disease and mortality.
Since these are relatively rare events, many simulated
individuals were needed to provide stable predictions
of rates that can be compared with ﬁeld data.
In the current phase of the project the compu-
tational demands are even higher because we are
developing and comparing a number of alternative
model formulations. These involve explicit simu-
lations of longitudinal patterns of parasitaemiawithin
hosts ; eﬀects of heterogeneity in transmission (to
simulate areas of focal transmission) ; decay in ac-
quired immunity against malaria; parasite drug re-
sistance; and diﬀerent models for preventive and
curative interventions, singly and combined.
To optimise all these models we are harnessing the
spare capacity of computers made available across
the internet by volunteers via the Berkeley Open
Infrastructure for Network Computing (BOINC)
(http://boinc.berkeley.edu/). The BOINC middle-
ware manages the allocation of tasks to volunteer
computers (scheduling), information exchange about
the project, and the corresponding security issues
both for our servers and for the volunteers. Using
this infrastructure we can ﬁt many models in parallel
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using genetic algorithms (Holland, 1975). Each
iteration of the ﬁtting process involves sending each
of the 61 standard scenarios to the volunteers, com-
bining their results to give measures of model ﬁt (loss
function) for each of the 10 objectives, and computing
an overall loss function, thus making possible
simultaneous multi-objective optimisation. The
project server generates new parameterisations and
tracks convergence. Fig. 2 illustrates how the overall
loss function computed from all 61 scenarios im-
proved during a typical implementation of this iter-
ative process. This run illustrates slow convergence
when many similar parameterisations are run in
parallel using the current genetic algorithm.
Within this framework, many diﬀerent optimiz-
ations can be carried out in parallel, with the main
limitations being the server capacity, the minimum
turn-around time on the work units sent out to the
volunteers, and the capacity of the research team to
process the results. These in turn mean that the time
needed to perform one optimization remains of the
order of several weeks or months with the current
algorithm.
OUTLOOK
The development of a comprehensive simulation
model for malaria epidemiology and control requires
a substantial trans-disciplinary eﬀort, and extra-
ordinary computing power. To this end, the Swiss
Tropical Institute has assembled a research team that
draws on skills from epidemiology, clinical medicine,
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Fig. 2. Loss function by iteration (example run). Each
point corresponds to the weighted average of the loss
functions over all 61 scenarios computed for a single
model parameterisation.
Table 2. Examples of interventions to combine in integrated control programmes
Intervention Deployment (examples) Combinations (examples)*
Prevention: Pre-erythrocytic
vaccine
EPI
Campaigns
Prevention: Asexual blood stage
vaccine
EPI
Campaigns
Prevention: Mosquito stage
transmission blocking vaccine
EPI
Campaigns
Prevention: Insecticide-treated nets Continuous social marketing
Continuous distribution with
ANC and or EPI integration
Targeted periodic campaigns
Mass distribution periodic
campaigns
Prevention: Indoor residual
spraying
Spray round campaigns
Prevention: Larviciding Application rounds
Treatment: IPTi EPI integration
Treatment: IPTp ANC integration
Treatment: ACT 1st line drug
Treatment: RDT Routine use
* Each column corresponds to one strategy of integrated or combined intervention programmes, making use of each of the
interventions indicated by shading. The project will simulate a very wide range of such combinations but not all are
possible : we will concentrate on analysing those most likely to be adapted to the particular epidemiological setting.
Abbreviations: ACT: artemisinin combination therapy; ANC: ante-natal clinic; EPI: Expanded Program on
Immunization; IPTi: intermittent preventive treatment in infants; IPTp: intermittent preventive treatment in pregnancy;
RDT: rapid diagnostic test.
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immunology, entomology, laboratory sciences,
health systems, mathematics, statistics, economics,
and computer sciences. The project is guided by an
international technical advisory group of malaria and
modelling experts. Finally, development of a valid
and useful comprehensive model such as this
requires access to numerous large and diverse ﬁeld
data sets informing the many dimensions required to
validate the model. For this we are fortunate to have
the collaboration of many partners and ﬁeld projects
from areas with endemic malaria and intend to
broaden further these links to obtain the strongest
possible validation.
It seems unlikely that any of the intervention
strategies we are simulating will prove to be a magic
bullet that will solve the problem of malaria for good.
On the other hand, the application of all existing
control interventions in all endemic areas is likely to
be highly cost-ineﬀective. Practical malaria control
experience indicates that the application of a well
selected limited menu of interventions in a given
area can capitalise on the advantages of each one.
Modelling integrated control strategies will thus be
of great utility for informing malaria control pro-
grammes about which strategies are most likely to be
cost-eﬀective under speciﬁc conditions.
In the light of the many uncertainties inherent in
such an exercise, it is crucial to supplement themodel
predictions with sensitivity analyses, development of
new models, and validation of model outputs against
accumulated ﬁeld data. The availability of the www.
malariacontrol.net volunteer computing resources
enables us not only to ﬁt many models, but also to
carry out the extensive analysis of model predictions,
and in the same way as climate modellers now make
predictions from ensembles of diﬀerent models, we
will be most conﬁdent about the predictions of dis-
ease models if we see that they are consistent across a
range of diﬀerent sets of assumptions. To judge how
robust are the simulation results we can also perform
probabilistic sensitivity analysis (PSA) to identify
the sensitivity of model predictions to the diﬀerent
parameters, thus helping to identify which model
assumptions are most important in determining the
predictions, and where further data may be needed
(Briggs, 2000). By including costing parameters in
the PSA we can also construct acceptability curves
for speciﬁc intervention strategies.
The ﬁnal set of model results will be made publicly
accessible. We are engaged in a consultation process
with various users including health planners; control
programme managers; international policy makers;
researchers, and members of industry, in order to
determine what kinds of user-interfaces will be re-
quired. These will allow the users to query speciﬁc
eco-epidemiological and health system scenarios,
and hence enable the models to take their place as
important tools for rational planning of malaria
control.
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